- Home
- ONBPO vs IMTXW Comparison
ONBPO vs IMTXW Comparison
Compare ONBPO & IMTXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONBPO
- IMTXW
- Stock Information
- Founded
- ONBPO N/A
- IMTXW N/A
- Country
- ONBPO United States
- IMTXW Germany
- Employees
- ONBPO 4267
- IMTXW 343
- Industry
- ONBPO Major Banks
- IMTXW Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ONBPO Finance
- IMTXW Health Care
- Exchange
- ONBPO Nasdaq
- IMTXW Nasdaq
- Market Cap
- ONBPO N/A
- IMTXW N/A
- IPO Year
- ONBPO N/A
- IMTXW N/A
- Fundamental
- Price
- ONBPO $25.32
- IMTXW $1.18
- Analyst Decision
- ONBPO
- IMTXW
- Analyst Count
- ONBPO 0
- IMTXW 0
- Target Price
- ONBPO N/A
- IMTXW N/A
- AVG Volume (30 Days)
- ONBPO N/A
- IMTXW N/A
- Earning Date
- ONBPO N/A
- IMTXW N/A
- Dividend Yield
- ONBPO N/A
- IMTXW N/A
- EPS Growth
- ONBPO N/A
- IMTXW N/A
- EPS
- ONBPO N/A
- IMTXW N/A
- Revenue
- ONBPO N/A
- IMTXW N/A
- Revenue This Year
- ONBPO N/A
- IMTXW N/A
- Revenue Next Year
- ONBPO N/A
- IMTXW N/A
- P/E Ratio
- ONBPO N/A
- IMTXW N/A
- Revenue Growth
- ONBPO N/A
- IMTXW N/A
- 52 Week Low
- ONBPO N/A
- IMTXW N/A
- 52 Week High
- ONBPO N/A
- IMTXW N/A
- Technical
- Relative Strength Index (RSI)
- ONBPO 46.88
- IMTXW N/A
- Support Level
- ONBPO $25.21
- IMTXW N/A
- Resistance Level
- ONBPO $25.70
- IMTXW N/A
- Average True Range (ATR)
- ONBPO 0.18
- IMTXW 0.00
- MACD
- ONBPO -0.01
- IMTXW 0.00
- Stochastic Oscillator
- ONBPO 36.01
- IMTXW 0.00
About ONBPO Old National Bancorp Depositary Shares Each Representing a 1/40th Interest in a Share of Series C Preferred Stock
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.
About IMTXW Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.